FI281574A - - Google Patents

Info

Publication number
FI281574A
FI281574A FI2815/74A FI281574A FI281574A FI 281574 A FI281574 A FI 281574A FI 2815/74 A FI2815/74 A FI 2815/74A FI 281574 A FI281574 A FI 281574A FI 281574 A FI281574 A FI 281574A
Authority
FI
Finland
Application number
FI2815/74A
Other languages
Finnish (fi)
Other versions
FI57414C (fi
FI57414B (fi
Inventor
R R Crenshaw
G M Luke
P Siminoff
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI281574A publication Critical patent/FI281574A/fi
Application granted granted Critical
Publication of FI57414B publication Critical patent/FI57414B/fi
Publication of FI57414C publication Critical patent/FI57414C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
FI2815/74A 1973-10-01 1974-09-26 Foerfarande foer framstaellning av i 6-,7-,8- och/eller 9-staellning substituerade 4-(substituerad amino)-1,3-dimetyl-1h-pyrazolo(3,4b)kinoliner med antiviral verkan FI57414C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/402,657 US4013665A (en) 1973-10-01 1973-10-01 Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines
US40265773 1973-10-01

Publications (3)

Publication Number Publication Date
FI281574A true FI281574A (xx) 1975-04-02
FI57414B FI57414B (fi) 1980-04-30
FI57414C FI57414C (fi) 1980-08-11

Family

ID=23592812

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2815/74A FI57414C (fi) 1973-10-01 1974-09-26 Foerfarande foer framstaellning av i 6-,7-,8- och/eller 9-staellning substituerade 4-(substituerad amino)-1,3-dimetyl-1h-pyrazolo(3,4b)kinoliner med antiviral verkan

Country Status (19)

Country Link
US (1) US4013665A (xx)
JP (1) JPS582948B2 (xx)
BE (1) BE820400A (xx)
CA (1) CA1032538A (xx)
CH (3) CH621552A5 (xx)
CY (1) CY1087A (xx)
DE (1) DE2446821A1 (xx)
DK (1) DK516274A (xx)
ES (1) ES430554A1 (xx)
FI (1) FI57414C (xx)
FR (1) FR2245369B1 (xx)
GB (1) GB1488692A (xx)
HK (1) HK59380A (xx)
KE (1) KE3086A (xx)
MY (1) MY8100219A (xx)
NL (1) NL7412959A (xx)
NO (1) NO143223C (xx)
SE (1) SE419760B (xx)
ZA (1) ZA746138B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848968B (en) * 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
WO1992018488A1 (fr) * 1991-04-10 1992-10-29 Japan Tobacco Inc. Nouveau derive d'oxazinone
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5614530A (en) * 1995-03-10 1997-03-25 Sterling Winthrop Inc. Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US6008226A (en) * 1995-03-10 1999-12-28 Sanofi-Synthelabo Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US5488055A (en) * 1995-03-10 1996-01-30 Sanofi Winthrop Inc. Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
CA2468015A1 (en) * 2001-11-27 2003-06-05 Merck & Co., Inc. 2-aminoquinoline compounds
CA2468159A1 (en) * 2001-11-27 2003-06-05 Merck & Co., Inc. 4-aminoquinoline compounds
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
NO343857B1 (no) * 2006-07-18 2019-06-24 Meda Ab Immunresponsmodifiserende skumformuleringer
CA2659733A1 (en) * 2006-07-31 2008-02-07 3M Innovative Properties Company Sterilized topical compositions of 1-(2-methylpropyl)-1h-imidazo[4,5-c]quinolin-4-amine
WO2010062559A1 (en) * 2008-10-28 2010-06-03 Schering Corporation Substituted pyrazoloquinolines and derivatives thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1445719A1 (de) * 1961-03-21 1969-01-09 Bayer Ag Verfahren zur Herstellung von 4-Chlor- oder 4-Brom-pyrazolo[3,4-]chinolinen
DE1152421B (de) * 1961-03-21 1963-08-08 Bayer Ag Verfahren zur Herstellung von 4-Hydroxy-pyrazolo[3, 4-b]chinolinen
DE1186867B (de) * 1961-05-03 1965-02-11 Bayer Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
DE1222885B (de) * 1962-05-25 1966-08-18 Bayer Ag Optische Aufhellungsmittel
US3600393A (en) * 1969-03-03 1971-08-17 Aldrich Chem Co Inc Dialkylamino alkylamino pyrazolo (3,4b) quinolines
JPS4826797A (xx) * 1971-08-07 1973-04-09
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
NL7412959A (nl) 1975-04-03
CH619712A5 (xx) 1980-10-15
JPS5059396A (xx) 1975-05-22
ES430554A1 (es) 1977-07-01
FI57414C (fi) 1980-08-11
CH622793A5 (xx) 1981-04-30
CY1087A (en) 1980-12-27
MY8100219A (en) 1981-12-31
HK59380A (en) 1980-10-31
NO143223B (no) 1980-09-22
DK516274A (xx) 1975-06-30
NO143223C (no) 1981-01-02
AU7379874A (en) 1976-04-01
SE419760B (sv) 1981-08-24
CA1032538A (en) 1978-06-06
SE7412275L (xx) 1975-04-02
GB1488692A (en) 1977-10-12
DE2446821A1 (de) 1975-04-10
USB402657I5 (xx) 1976-04-06
BE820400A (fr) 1975-03-26
FI57414B (fi) 1980-04-30
JPS582948B2 (ja) 1983-01-19
KE3086A (en) 1980-11-07
FR2245369A1 (xx) 1975-04-25
US4013665A (en) 1977-03-22
FR2245369B1 (xx) 1978-07-28
ZA746138B (en) 1975-10-29
NO743528L (xx) 1975-04-28
CH621552A5 (xx) 1981-02-13

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU465372B2 (xx)
AR201235Q (xx)
AR201231Q (xx)
FR2245369B1 (xx)
AU465434B2 (xx)
AU450229B2 (xx)
AR201229Q (xx)
AU466283B2 (xx)
AU476696B2 (xx)
AR199451A1 (xx)
AR200256A1 (xx)
AR193950A1 (xx)
AR201432A1 (xx)
AR210729A1 (xx)
AU461342B2 (xx)
AR200885A1 (xx)
AR197627A1 (xx)
AR196382A1 (xx)
AR195311A1 (xx)
AR195948A1 (xx)
AU447540B2 (xx)
AR196123Q (xx)
AU1891376A (xx)
AR196212Q (xx)